WallStreetZenWallStreetZen

NASDAQ: PVLA
Palvella Therapeutics Inc Stock Ownership - Who owns Palvella Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Palvella Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kathleen GoinCOO2026-08-192,148$9.08
$19.50kBuy
Kathleen GoinCOO2026-08-192,154$7.14
$15.38kBuy
Kathleen GoinCOO2026-08-19302$156.77
$47.34kSell
Kathleen GoinCOO2026-08-19102$155.59
$15.87kSell
Kathleen GoinCOO2026-08-19400$153.00
$61.20kSell
Kathleen GoinCOO2026-08-191,998$151.80
$303.29kSell
Kathleen GoinCOO2026-08-191,500$151.39
$227.08kSell
Kathleen GoinCOO2026-07-15522$147.14
$76.81kSell
Kathleen GoinCOO2026-07-152,154$7.14
$15.38kBuy
Kathleen GoinCOO2026-07-151,911$150.25
$287.13kSell

1 of 6

PVLA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PVLA insiders and whales buy or sell their stock.

PVLA Shareholders

What type of owners hold Palvella Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aquilo Capital Management LLC25.51%3,675,530$552.54MInsider
Wes Kaupinen11.15%1,607,228$241.61MInsider
George M. Jenkins1.47%212,158$31.89MInsider
Adar1 Capital Management LLC1.00%144,641$21.74MInsider
Dellora Investments LP0.98%141,079$21.21MInsider
Todd C. Davis0.78%112,547$16.92MInsider
Chau Quang Khuong0.45%65,398$9.83MInsider
Allan Reine0.45%65,000$9.77MInsider
Elaine J. Heron0.37%53,691$8.07MInsider
Bvf Partners L P0.27%38,961$5.86MInsider

1 of 3

PVLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PVLA0.10%43.12%Net BuyingNet Buying
AUPH0.06%14.08%Net BuyingNet Buying
URGN0.09%20.41%Net SellingNet Selling
SRPT0.10%29.44%Net Selling
KLRA0.09%85.25%Net BuyingNet Buying
View Top Biotech Stocks

Palvella Therapeutics Stock Ownership FAQ

Who owns Palvella Therapeutics?

Palvella Therapeutics (NASDAQ: PVLA) is owned by 0.10% institutional shareholders, 43.12% Palvella Therapeutics insiders, and 56.78% retail investors. Aquilo Capital Management LLC is the largest individual Palvella Therapeutics shareholder, owning 3.68M shares representing 25.51% of the company. Aquilo Capital Management LLC's Palvella Therapeutics shares are currently valued at $551.22M.

If you're new to stock investing, here's how to buy Palvella Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.